is semaglutide for weight loss covered by insurance 7 FAQs About and Novo's top US exec wants

The fact that SURMOUNT-5, known as a Phase 3b trial, is also being sponsored by Eli Lilly, whose valuation of about $870bn (668bn) makes it the worlds biggest pharmaceutical giant by value, is also an indication of just how the findings from the study are likely to pan out when they are released at the end of this year or early in 2025

We dont have that granularity of evidence yet, but we have general trends from other studies, says Tchang

That's in contrast to single -agonist medications like Novo Nordisks Wegovy and Ozempic, which stimulate the bodys GLP-1 receptors to slow digestion, causing people to feel fuller longer after eating

The Ozempic SmPC includes warnings about the risk of dehydration and potential acute kidney injury with significant gastrointestinal losses

A March 2021 study published in The New England Journal of Medicine found that using Ozempic can result in weight loss